Williams, CL, Johnstone, BM, Kesterson, JG, Javor, KA, Schmetzer, AD. Evaluation of antipsychotic and concomitant medication use patterns in patients with schizophrenia. Med Care
1999; 37 (suppl 4): AS816.
Lacro, JP, Dunn, LB, Dolder, CR, Leckband, SG, Jeste, DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry
2002; 63: 892–909.
Higashi, K, Medic, G, Littlewood, KJ, Diez, T, Granström, O, DeHert, M.
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol
2013; 3: 200–18.
Novick, D, Haro, JM, Suarez, D, Perez, V, Dittmann, RW, Haddad, PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res
2010; 176: 109–13.
Ascher-Svanum, H, Faries, DE, Zhu, B, Ernst, FR, Swartz, MS, Swanson, JW. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry
2006; 67: 453–60.
McCrone, P, Dhanasiri, S, Patel, A, Knapp, M, Lawton-Smith, S.
Paying the Price – The Cost of Mental Health Care in England to 2026. King's Fund, 2008.
Dilla, T, Ciudad, A, Alvarez, M.
Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia. Patient Prefer Adherence
2013; 7: 275–84.
Knapp, M, King, D, Pugner, K, Lapuerta, P.
Non-adherence to antipsychotic medication regimens: associations with resource use and costs. Br J Psychiatry
2004; 184: 509–16.
Xia, J, Merinder, LB, Belgamwar, MR. Psychoeducation for schizophrenia. Cochrane Database Syst Rev
2011; 6: CD002831.
Kissing, W, Seeman, U.
Psychoeducation in the context of integrated care [in German]. In (eds Bauml, J, Pitschel-Walz, G) Psychoedukation Bei Schizophrenen Erkrankungen. Schattauer, 2008.
Thompson, K, Kulkarni, J, Sergejew, AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res
2000; 42: 241–7.
ECDEU Assessment Manual for Psychopharmacology
. US Department of Health, Education and Welfare, 1976.
Mueser, KT, McGurk, SR. Schizophrenia. Lancet
2004; 363: 2063–72.
Diflorio, A, Jones, I.
Is sex important? Gender differences in bipolar disorder. Int Rev Psychiatry
2010; 22: 437–52.
The many forms of bipolar disorder: a modern look at an old illness. J Affect Disord
2004; 79: S3–8.
Tacchi, M-J, Scott, J.
Improving Adherence in Schizophrenia and Bipolar Disorders. John Wiley & Sons, 2005.
Kemmler, G, Hummer, M, Widschwendter, C, Fleischhacker, WW. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis. Arch Gen Psychiatry
2005; 62: 1305–12.
Villeneuve, K, Potvin, S, Lesage, A, Nicole, L.
Meta-analysis of rates of drop-out from psychosocial treatment among persons with schizophrenia spectrum disorder. Schizophr Res
2010; 121: 266–70.
Bauml, J, Frobose, T, Kraemer, S, et al. Psychoeducation: a basic psychotherapeutic intervention for patients with schizophrenia and their families. Schizophr Bull
2006; 32: S1–9.
Care Quality Commission. Survey of People who use Community Mental Health Services 2012 – Full National Results with 2011 Comparisons. CQC, 2012.